Christopher W Mount
Affiliations: | Stanford University, Palo Alto, CA |
Google:
"Christopher Mount"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Larson RC, Kann MC, Graham C, et al. (2023) Anti-TACI single and dual-targeting CAR T cells overcome BCMA antigen loss in multiple myeloma. Nature Communications. 14: 7509 |
| Mount CW, Gonzalez Castro LN. (2022) Advances in Chimeric Antigen Receptor (CAR) T-Cell Therapies for the Treatment of Primary Brain Tumors. Antibodies (Basel, Switzerland). 11 |
| Majzner RG, Ramakrishna S, Yeom KW, et al. (2022) GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas. Nature |
| Theruvath J, Sotillo E, Mount CW, et al. (2020) Locoregionally administered B7-H3-targeted CAR T cells for treatment of atypical teratoid/rhabdoid tumors. Nature Medicine |
| Mount CW, Yalçın B, Cunliffe-Koehler K, et al. (2019) Monosynaptic tracing maps brain-wide afferent oligodendrocyte precursor cell connectivity. Elife. 8 |
| Majzner RG, Theruvath JL, Nellan A, et al. (2019) CAR T cells targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Mount CW, Yalçın B, Cunliffe-Koehler K, et al. (2019) Author response: Monosynaptic tracing maps brain-wide afferent oligodendrocyte precursor cell connectivity Elife |
| Filbin MG, Tirosh I, Hovestadt V, et al. (2018) Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq. Science (New York, N.Y.). 360: 331-335 |
| Mount CW, Majzner RG, Sundaresh S, et al. (2018) Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M diffuse midline gliomas. Nature Medicine |
| Majzner RG, Mount C, Sundaresh S, et al. (2018) Abstract PR04: GD2-directed chimeric antigen receptor T cells mediate potent antitumor effect and cure in xenograft models of diffuse intrinsic pontine glioma Cancer Research. 78 |